Th. Eichhold et al., ISOLATION AND QUANTIFICATION OF FLUOROACETATE IN RAT-TISSUES, FOLLOWING DOSING OF Z-PHE-ALA-CH2-F, A PEPTIDYL FLUOROMETHYL KETONE PROTEASE INHIBITOR, Journal of pharmaceutical and biomedical analysis, 16(3), 1997, pp. 459-467
Peptidyl fluoromethyl ketones (PFMK) are irreversible inhibitors of ca
thepsin B, a cysteine proteinase thought to be involved in the degrada
tion of cartilage. It has been speculated that PFMK inhibitors may met
abolize in rodents to form fluoroacetate (FAC), an extremely toxic poi
son. A highly selective and sensitive separation and detection scheme
was developed to measure trace levels of FAC in rat tissues following
PFMK dosing. The procedure consisted of extracting FAC from tissue and
spiking the extract with [O-18](2)-fluoroacetate (O-18-FAC) as an int
ernal standard. FAC and O-18-FAC were further isolated from matrix com
ponents using ion-exchange, solid-phase extraction. The pentafluoroben
zyl esters of FAC and O-18-FAC were formed to facilitate the chromatog
raphic separation. Two-dimensional gas chromatography coupled with sel
ected-ion-monitoring detection provided the final measurement. The ass
ay had a limit of detection of 2 ng FAC per g tissue, and was capable
of accurately quantitating as little as 10 ng FAC per g tissue with a
SIN ratio of 40:1. Linearity was established over two orders of magnit
ude, from 2-500 ng ml(-1), with 5 mu l injected on-column. The method
was used to demonstrate that FAC was formed in rats following dosing w
ith Z-Phe-Ala-CH2-F, a PFMK cathepsin enzyme inhibitor. (C) 1997 Elsev
ier Science B.V.